United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - phentolamine mesylate 5 mg in 1 ml - phentolamine mesylate for injection is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. phentolamine mesylate for injection is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. phentolamine mesylate for injection is also indicated for the diagnosis of pheochromocytoma by the phentolamine blocking test. myocardial infarction, history of myocardial infarction, coronary insufficiency, angina, or other evidence suggestive of coronary artery disease; hypersensitivity to phentolamine or related compounds.

United States - English - NLM (National Library of Medicine)

tagi pharma, inc. - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - phentolamine mesylate for injection, usp is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. phentolamine mesylate for injection, usp is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. phentolamine mesylate for injection, usp is also indicated for the diagnosis of pheochromocytoma by the phentolamine mesylate for injection, usp blocking test. myocardial infarction, history of myocardial infarction, coronary insufficiency, angina or other evidence suggestive of coronary artery disease; hypersensitivity to phentolamine or related compounds.

United States - English - NLM (National Library of Medicine)

precision dose inc. - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - phentolamine mesylate for injection, usp is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision. phentolamine mesylate for injection, usp is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine. phentolamine mesylate for injection, usp is also indicated for the diagnosis of pheochromocytoma by the phentolamine mesylate for injection, usp blocking test. myocardial infarction, history of myocardial infarction, coronary insufficiency, angina or other evidence suggestive of coronary artery disease; hypersensitivity to phentolamine or related compounds.

United States - English - NLM (National Library of Medicine)

septodont, inc. - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - phentolamine mesylate 0.235 mg in 1 ml - oraverse is contraindicated in patients with: hypersensitivity to the active substance or to any ingredients in the formulation pregnancy category c risk summary there are no available data with oraverse in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. in animal toxicology studies, phentolamine administered orally to pregnant mice and rats during the period of organogenesis resulted in skeletal immaturity and decreased growth in the offspring at doses at least 24-times the recommended dose. additionally, a lower rate of implantation was seen in pregnant rats treated with phentolamine at least 60-times the recommended dose. no malformations or embryofetal deaths were observed in the offspring of pregnant mice, rats, and rabbits administered phentolamine during the period of organogenesis at doses 24-, 60-, and 20-times, respectively, the recommended dose [see data]. the estimated background risk of major birth defects and miscarriage for the indicated population is

United States - English - NLM (National Library of Medicine)

wuhan longke biotechnology co., ltd. - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) -

United States - English - NLM (National Library of Medicine)

novalar pharmaceuticals - phentolamine mesylate (unii: y7543e5k9t) (phentolamine - unii:z468598hbv) - injection, solution - 0.4 mg in 1.7 ml - oraverse is indicated for reversal of the soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. oraverse is not recommended for use in children less than 6 years of age or weighing less than 15 kg (33 lbs). none. pregnancy category c there are no adequate and well-controlled studies in pregnant women. oraverse should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of phentolamine to pregnant rats and mice at doses at least 24 times the recommended dose (based on a 60 kg human) resulted in slightly decreased growth and slight skeletal immaturity of the fetuses. immaturity was manifested by increased incidence of incomplete or unossified calcaneal and phalangeal nuclei of the hind limb and of incompletely ossified sternebrae. at oral phentolamine doses at least 60 times the recommended dose (ba

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - phentolamine mesylate (unii: y7543e5k9t) (phentolamine mesylate - unii:y7543e5k9t) -

Canada - English - Health Canada

sandoz canada incorporated - phentolamine mesylate - solution - 5mg - phentolamine mesylate 5mg - non-selective alfa-adrenergic blocking agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - phentolamine mesilate - solution for injection - 10mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (canada) - phentolamine mesilate - solution for injection - 5mg/1ml